Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion type Assertion NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_head.
- NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_provenance.
- NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion evidence source_evidence_literature NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_provenance.
- NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion SIO_000772 16507781 NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_provenance.
- NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion wasDerivedFrom befree-20140225 NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_provenance.
- NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_assertion wasGeneratedBy ECO_0000203 NP629516.RAUSyuJ0DUwOG-H6om-zccAbx2ZlATjCC4sTExJYbSOiY130_provenance.